Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06517732
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-18
Brief Title:
Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa HS in Routine Clinical Practice in the Russian Federation
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Prospective Observational Multicenter Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa HS in Routine Clinical Practice in the Russian Federation ANIMA-R
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ANIMA-R
Brief Summary:
ANIMA-R is an observational prospective non-interventional multicenter study to assess real-world effectiveness of secukinumab in the treatment of Hidradenitis Suppurativa HS
Detailed Description:
The index date will be the date of secukinumab initiation During the study data will be collected from patients receiving routine secukinumab treatment which is representative of the actual patient population
The attending physician will decide whether to prescribe secukinumab based on the approved instructions for medical use in a routine clinical setting regardless of the patients participation in a non-interventional study
The attending physician will decide whether to prescribe secukinumab based on the approved instructions for medical use in a routine clinical setting regardless of the patients participation in a non-interventional study
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: